{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T22:37:17Z","timestamp":1792103837326,"version":"4.4.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Assessment of liver fibrosis is crucial for antiviral decision-making in chronic hepatitis B virus (HBV)-infected patients with low alanine aminotransferase (ALT) levels, but accurate assessment data of Transient elastography (TE) are lacking in individuals with steatosis. We aimed to evaluate the accuracy of TE in determining liver fibrosis in individuals with hepatic steatosis and associated factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 218 patients with chronic HBV infection from China were included in the study. Logistic regression analysis was conducted to identify factors influencing liver stiffness measurement (LSM). Significant fibrosis cut-off values were calculated by receiver operating characteristic (ROC) curve based on controlled attenuation parameter (CAP) stratification, and a TE diagnostic flowchart was thus developed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 218 patients, the prevalence of steatosis was 36.7%. In individuals without significant fibrosis (S0-S1), moderate-to-severe steatosis increases LSM values. Of 60 patients with histological stage S0-S1 combined with steatosis, 21 (35%) were misdiagnosed as significant fibrosis or above. Multivariate logistic analysis revealed that CAP was an independent risk factor for misdiagnosis (OR = 1.03,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). ROC curve analysis showed that 273 dB\/m was the optimal cut-off value for misdiagnosis. For patients with CAP = 238\u2013273 dB\/m and CAP \u2265273 dB\/m, the AUROC of TE in diagnosing significant fibrosis was 0.880 and 0.771, respectively, using cut-off values of 8.3 kPa and 9.6 kPa. The results are consistent with histological diagnosis (all Kappa values &gt;0.5,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>In chronic HBV-infected patients without significant fibrosis but with moderate-to-severe hepatic steatosis, the degree of liver fibrosis may be overestimated. A TE diagnostic flowchart based on the CAP stratification may enhance the accuracy of liver fibrosis diagnosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjg.sjg_395_25","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:00:51Z","timestamp":1767621651000},"page":"214-221","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic value of transient elastography in assessing the degree of liver fibrosis in chronic hepatitis B patients with low alanine aminotransferase levels and concomitant hepatic steatosis"],"prefix":"10.4103","volume":"32","author":[{"given":"Aili","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, The First Affiliated Hospital of Kunming Medical University, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatology, The Third People\u2019s Hospital of Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaie","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, The First Affiliated Hospital of Kunming Medical University, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"R1-20261015","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022:A modelling study","volume":"8","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R2-20261015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2468-1253(19)30342-5","article-title":"Liver diseases in the Asia-pacific region:A lancet gastroenterology and hepatology commission","volume":"5","author":"Sarin","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R3-20261015","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1038\/ajg.2009.248","article-title":"Histological disease in Asian-Americans with chronic hepatitis b, high hepatitis b virus DNA, and normal alanine aminotransferase levels","volume":"104","author":"Nguyen","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"R4-20261015","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis b","volume":"52","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"R5-20261015","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/flgastro-2021-102064","article-title":"EASL clinical practice guidelines:Non-invasive liver tests for evaluation of liver disease severity and prognosis","volume":"13","author":"Archer","year":"2022","journal-title":"Frontline Gastroenterol"},{"key":"R6-20261015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH clinical practice guidelines:Non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"R7-20261015","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1053\/j.gastro.2017.03.016","article-title":"American gastroenterological association institute technical review on the role of elastography in chronic liver diseases","volume":"152","author":"Singh","year":"2017","journal-title":"Gastroenterology"},{"key":"R8-20261015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J Hepatol"},{"key":"R9-20261015","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis b:AASLD 2018 hepatitis b guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"R10-20261015","first-page":"769","article-title":"Guidelines for prevention and treatment of chronic hepatitis b","volume":"9","author":"Wang","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"R11-20261015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cgh.2017.09.044","article-title":"Association between hepatic steatosis, measured by controlled attenuation parameter, and fibrosis burden in chronic hepatitis b","volume":"16","author":"Seto","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R12-20261015","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1111\/j.1365-2036.2011.04668.x","article-title":"Reliability of liver stiffness measurement in non-alcoholic fatty liver disease:The effects of body mass index","volume":"33","author":"Petta","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R13-20261015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1872-034X.2012.01068.x","article-title":"Impact of mild to moderate elevations of alanine aminotransferase on liver stiffness measurement in chronic hepatitis b patients during antiviral therapy","volume":"43","author":"Yan","year":"2013","journal-title":"Hepatol Res"},{"key":"R14-20261015","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1872-034X.2011.00797.x","article-title":"Liver stiffness in extrahepatic cholestasis correlates positively with bilirubin and negatively with alanine aminotransferase","volume":"41","author":"Harata","year":"2011","journal-title":"Hepatol Res"},{"key":"R15-20261015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019:A systematic review and meta-analysis","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R16-20261015","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/CM9.0000000000002277","article-title":"Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021:Systematic review and meta-analysis","volume":"135","author":"Liu","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"R17-20261015","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0168-8278(91)90084-O","article-title":"Classification of chronic viral hepatitis:A need for reassessment","volume":"13","author":"Scheuer","year":"1991","journal-title":"J Hepatol"},{"key":"R18-20261015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/a-0838-9937","article-title":"The EFSUMB guidelines and recommendations for the clinical practice of elastography in non-hepatic applications:Update 2018","volume":"40","author":"Saftoiu","year":"2019","journal-title":"Ultraschall Med"},{"key":"R19-20261015","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/gutjnl-2020-321299","article-title":"Guidelines on the use of liver biopsy in clinical practice from the British society of gastroenterology, the royal college of radiologists and the royal college of pathology","volume":"69","author":"Neuberger","year":"2020","journal-title":"Gut"},{"key":"R20-20261015","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1053\/j.gastro.2017.03.017","article-title":"American gastroenterological association institute guideline on the role of elastography in the evaluation of liver fibrosis","volume":"152","author":"Lim","year":"2017","journal-title":"Gastroenterology"},{"key":"R21-20261015","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.dld.2011.08.004","article-title":"Improving transient elastography performance for detecting hepatitis b cirrhosis","volume":"44","author":"Chen","year":"2012","journal-title":"Dig Liver Dis"},{"key":"R22-20261015","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jgh.12840","article-title":"Transient elastography compared to serum markers to predict liver fibrosis in a cohort of Chinese patients with chronic hepatitis b","volume":"30","author":"Jia","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"R23-20261015","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1111\/liv.12808","article-title":"Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis:A multicentre, retrospective study","volume":"35","author":"Seo","year":"2015","journal-title":"Liver Int"},{"key":"R24-20261015","first-page":"182","article-title":"Consensus on clinical application of transient elastography detecting liver fibrosis:A 2018 update","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"R25-20261015","doi-asserted-by":"crossref","first-page":"101957","DOI":"10.1016\/j.clinre.2022.101957","article-title":"Hepatic steatosis leads to overestimation of liver stiffness measurement in both chronic hepatitis b and metabolic-associated fatty liver disease patients","volume":"46","author":"Liu","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R26-20261015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/apt.15298","article-title":"Moderate to severe hepatic steatosis leads to overestimation of liver stiffness measurement in chronic hepatitis b patients without significant fibrosis","volume":"50","author":"Shen","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"R27-20261015","doi-asserted-by":"crossref","first-page":"16072","DOI":"10.18632\/aging.103522","article-title":"Controlled attenuation parameter value-based diagnostic algorithm improves the accuracy of liver stiffness measurement in chronic hepatitis b patients","volume":"12","author":"Fan","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"R28-20261015","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/jvh.13640","article-title":"Effect of liver steatosis on liver stiffness measurement in chronic hepatitis b patients with normal serum alanine aminotransferase levels:A multicentre cohort study","volume":"29","author":"Wang","year":"2022","journal-title":"J Viral Hepat"},{"key":"R29-20261015","first-page":"832","article-title":"The impact of steatosis on liver stiffness measurement in patients with chronic hepatitis b","volume":"57","author":"Kim","year":"2010","journal-title":"Hepatogastroenterology"},{"key":"R30-20261015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3350\/cmh.2023.0004","article-title":"Impact of fatty liver on long-term outcomes in chronic hepatitis b:A systematic review and matched analysis of individual patient data meta-analysis","volume":"29","author":"Wong","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"R31-20261015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s13098-022-00930-w","article-title":"Age patterns of nonalcoholic fatty liver disease incidence:Heterogeneous associations with metabolic changes","volume":"14","author":"Lin","year":"2022","journal-title":"Diabetol Metab Syndr"},{"issue":"9","key":"R32-20261015","doi-asserted-by":"crossref","first-page":"e00196","DOI":"10.14309\/ctg.0000000000000196","article-title":"Incidence, factors, and patient-level data for spontaneous HBsAg Seroclearance:A cohort study of 11,264 patients","volume":"11","author":"Yeo","year":"2020","journal-title":"Clin Transl Gastroenterol"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_395_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:00:44Z","timestamp":1792047644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_395_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_395_25","relation":{},"ISSN":["1319-3767","1998-4049"],"issn-type":[{"value":"1319-3767","type":"print"},{"value":"1998-4049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"2025-10-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}